ELVN
Price
$20.52
Change
+$0.67 (+3.38%)
Updated
May 2, 02:36 PM (EDT)
Capitalization
973.96M
6 days until earnings call
ONCY
Price
$0.55
Change
-$0.02 (-3.51%)
Updated
May 1 closing price
Capitalization
48.85M
Earnings call today
Ad is loading...

ELVN vs ONCY

Header iconELVN vs ONCY Comparison
Open Charts ELVN vs ONCYBanner chart's image
Enliven Therapeutics
Price$20.52
Change+$0.67 (+3.38%)
Volume$100
Capitalization973.96M
Oncolytics Biotech
Price$0.55
Change-$0.02 (-3.51%)
Volume$260.3K
Capitalization48.85M
ELVN vs ONCY Comparison Chart
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVN vs. ONCY commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a StrongBuy and ONCY is a Hold.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (ELVN: $19.85 vs. ONCY: $0.55)
Brand notoriety: ELVN and ONCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 76% vs. ONCY: 86%
Market capitalization -- ELVN: $973.96M vs. ONCY: $48.85M
ELVN [@Biotechnology] is valued at $973.96M. ONCY’s [@Biotechnology] market capitalization is $48.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whileONCY’s FA Score has 0 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • ONCY’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVN is a better buy in the long-term than ONCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 6 TA indicator(s) are bullish while ONCY’s TA Score has 5 bullish TA indicator(s).

  • ELVN’s TA Score: 6 bullish, 3 bearish.
  • ONCY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than ONCY.

Price Growth

ELVN (@Biotechnology) experienced а +8.47% price change this week, while ONCY (@Biotechnology) price change was -5.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +8.33%, and the average quarterly price growth was -5.51%.

Reported Earning Dates

ELVN is expected to report earnings on Aug 07, 2025.

ONCY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($974M) has a higher market cap than ONCY($48.8M). ELVN YTD gains are higher at: -11.778 vs. ONCY (-39.812). ONCY has higher annual earnings (EBITDA): -34.56M vs. ELVN (-104.24M). ELVN has more cash in the bank: 313M vs. ONCY (15.9M). ELVN has less debt than ONCY: ELVN (0) vs ONCY (1.06M). ELVN (0) and ONCY (0) have equivalent revenues.
ELVNONCYELVN / ONCY
Capitalization974M48.8M1,996%
EBITDA-104.24M-34.56M302%
Gain YTD-11.778-39.81230%
P/E RatioN/AN/A-
Revenue00-
Total Cash313M15.9M1,969%
Total Debt01.06M-
FUNDAMENTALS RATINGS
ONCY: Fundamental Ratings
ONCY
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELVNONCY
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPSC0.560.01
+2.55%
Century Therapeutics
CYD15.300.13
+0.86%
China Yuchai International Ltd
PH610.125.06
+0.84%
Parker-Hannifin Corp
HLIO27.490.23
+0.84%
Helios Technologies
FYBR36.410.16
+0.44%
Frontier Communications Parent

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with APGE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+4.80%
APGE - ELVN
51%
Loosely correlated
-0.13%
OCUL - ELVN
50%
Loosely correlated
+2.77%
ERAS - ELVN
50%
Loosely correlated
+2.05%
CRNX - ELVN
48%
Loosely correlated
+0.39%
COGT - ELVN
48%
Loosely correlated
+8.06%
More

ONCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCY has been loosely correlated with SRRK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCY jumps, then SRRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCY
1D Price
Change %
ONCY100%
-3.64%
SRRK - ONCY
40%
Loosely correlated
-0.46%
ABCL - ONCY
35%
Loosely correlated
-4.60%
RXRX - ONCY
32%
Poorly correlated
-1.61%
IMTX - ONCY
30%
Poorly correlated
+0.20%
CVM - ONCY
29%
Poorly correlated
-8.28%
More